Dr. Kelly Zhang is a Senior Scientist and Group Leader in Small Molecule Analytical Chemistry at Genentech. Prior to joining Genentech, she worked at Allergan and Pfizer. Kelly has 15 years of pharmaceutical industry experience leading analytical activities of drug development from discovery to NDA for therapies in oncology such as Cotellic™ (Cobimetinib), immunology, ophthalmology and metabolic diseases etc. She serves as Subject Matter of Expert in analytical method

development, validation, specifications, GMP release, stability, LIMS, automation and technology transfer. She has authored regulatory filings for over 10 NCEs. Kelly received her Ph.D. in Analytical Chemistry from Wuhan University. Kelly has published 35 peer reviewed papers and presented over 20 conference lectures as invited speaker.